Identifying therapeutic targets for schizophrenia

There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Karli Montague-Cardoso
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/e8c68a00f79b4d2a84f00ab418323797
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e8c68a00f79b4d2a84f00ab418323797
record_format	dspace
spelling	oai:doaj.org-article:e8c68a00f79b4d2a84f00ab4183237972021-12-02T17:52:40ZIdentifying therapeutic targets for schizophrenia10.1038/s42003-021-02270-32399-3642https://doaj.org/article/e8c68a00f79b4d2a84f00ab4183237972021-06-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02270-3https://doaj.org/toc/2399-3642There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover the precise pathomechanism. Their study sheds further light on the role of mTOR in Schizophrenia and could inform the development of future therapeutic strategies for the condition.Karli Montague-CardosoNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Biology (General) QH301-705.5
spellingShingle	Biology (General) QH301-705.5 Karli Montague-Cardoso Identifying therapeutic targets for schizophrenia
description	There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover the precise pathomechanism. Their study sheds further light on the role of mTOR in Schizophrenia and could inform the development of future therapeutic strategies for the condition.
format	article
author	Karli Montague-Cardoso
author_facet	Karli Montague-Cardoso
author_sort	Karli Montague-Cardoso
title	Identifying therapeutic targets for schizophrenia
title_short	Identifying therapeutic targets for schizophrenia
title_full	Identifying therapeutic targets for schizophrenia
title_fullStr	Identifying therapeutic targets for schizophrenia
title_full_unstemmed	Identifying therapeutic targets for schizophrenia
title_sort	identifying therapeutic targets for schizophrenia
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/e8c68a00f79b4d2a84f00ab418323797
work_keys_str_mv	AT karlimontaguecardoso identifyingtherapeutictargetsforschizophrenia
_version_	1718379202781118464

Identifying therapeutic targets for schizophrenia

Ejemplares similares